CrestPoint Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$392K |
| 2 |
AbbVie
ABBV
|
+$357K |
| 3 |
CELG
Celgene Corp
CELG
|
+$324K |
| 4 |
Meta Platforms (Facebook)
META
|
+$288K |
| 5 |
Southern Company
SO
|
+$272K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$1.09M |
| 2 |
EQT Corp
EQT
|
+$1.02M |
| 3 |
NOV
NOV
|
+$888K |
| 4 |
Dana Inc
DAN
|
+$850K |
| 5 |
Gilead Sciences
GILD
|
+$635K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.97% |
| 2 | Financials | 12.94% |
| 3 | Healthcare | 12.05% |
| 4 | Industrials | 11.65% |
| 5 | Energy | 9.63% |
Similar funds
CrestPoint Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, CrestPoint Capital Management held 205 positions worth $177M, up 1.5% from $174M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
CrestPoint Capital Management withdrew a net $5.66M in Q4 2015, closing 14 positions and reducing 77 holdings. Its most notable exit was Genesee & Wyoming Inc., an estimated $1.09M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
Against the trend, CrestPoint Capital Management opened a new position in AbbVie worth $367K.
- CrestPoint Capital Management's largest Q4 2015 buy was AbbVie: 6,200 shares worth $367K.
- CrestPoint Capital Management added most to DONNELLEY R R & SONS CO in Q4 2015, an estimated $392K increase.
- CrestPoint Capital Management's biggest Q4 2015 reduction was EQT Corp, cutting an estimated $1.02M.
- CrestPoint Capital Management fully exited Genesee & Wyoming Inc. in Q4 2015, selling an estimated $1.09M.
- CrestPoint Capital Management's ten largest holdings make up 21% of its $177M portfolio in Q4 2015.
- CrestPoint Capital Management opened 18 new positions and closed 14 in Q4 2015.
- CrestPoint Capital Management's portfolio value rose 1.5% quarter-over-quarter to $177M.
Based on CrestPoint Capital Management's 13F filing for Q4 2015, filed 12 Jan 2016.